EUVIMEDEUVIMED entdecken
Crossref

S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis

Wentao Xu, Huina Li, Wei Zhang, Ge Bai, Chengyong Shen, Kejing Zhang

Molecular Cell · 2026

DOI: 10.1016/j.molcel.2026.04.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Wentao Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology of First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Transla…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TDP43 inclusion bodies are widely present in the majority of patients with familial and sporadic amyotrophic lateral sclerosis (ALS). The mechanisms regulating TDP43 solubility remain incompletely understood. Here, we report that TDP43 undergoes S-acylation primarily at the Cys244 residue by the S-acyltransferase zDHHC23. This S-acylation maintains the liquid-like properties of TDP43 by reducing the aberrant interaction with poly(ADP-ribose) polymerase 1 (PARP1) and PARylated proteins, thereby countering the pathological condensation of TDP43. S-acylation-deficient TDP43 inclusions sequester the translational machinery and inhibit cytoplasmic protein translation, ultimately resulting in neurotoxicity. Importantly, TDP43 S-acylation is decreased in the familial ALS-associated TDP43 mutants as well as in SOD1-G93A mice and C9orf72-ALS induced pluripotent stem cell (iPSC)-derived neurons, suggesting the widespread involvement of TDP43 S-acylation in ALS pathogenesis. Our findings reveal an undescribed modification of TDP43 and provide deeper insight into the regulation of TDP43 pathological condensation in ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDNA-Binding ProteinsAnimalsHumansAcylationAcyltransferasesMiceInduced Pluripotent Stem CellsMutationMice, TransgenicInclusion BodiesNeuronsDisease Models, AnimalHEK293 Cells

Stichwörter der Autor:innen

S-acylationTDP43aggregationamyotrophic lateral sclerosiscondensation

Substanzen

DNA-Binding ProteinsTARDBP protein, humanAcyltransferasesTardbp protein, mouse

Autor:innen und Institutionen

  • Department of Neurology of First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou 310…
  • Department of Neurology of Second Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China; MOE Frontier Science Center for Brain Research and Br…

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Xu, W., Li, H., Zhang, W., Bai, G., Shen, C., & Zhang, K. (2026). S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.04.016

Vancouver

Xu W, Li H, Zhang W, Bai G, Shen C, Zhang K. S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.04.016

BibTeX
@article{Xu2026,
  author = {Xu, Wentao and Li, Huina and Zhang, Wei and Bai, Ge and Shen, Chengyong and Zhang, Kejing},
  title = {S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis},
  journal = {Molecular Cell},
  year = {2026},
  doi = {10.1016/j.molcel.2026.04.016}
}
Kostenlos starten →